REGENXBIO Common Stock Stock Performance
as on June 19, 2026 at 2:16 pm IST
Day's Low
Day's High
$7.85$8.57
-0.64%
Downside
9.87%
Upside
52 Week's Low
52 Week's High
$5.46$16.1930.06%
Downside
107.56%
Upside
REGENXBIO Common Stock share price movements today
- Previous Close
- $7.90
- Open
- $8.38
- Volume
- 1.4M
- Day's Low - High
- $7.85 - $8.57
- 52 Week Low - High
- $5.46 - $16.19
REGENXBIO Common Stock Historical Returns
- 1 Month Return
- + 37.81 %
- 3 Month Return
- -6.7 %
- 1 Year Return
- -8.98 %
- 3 Year Return
- -60.76 %
- 5 Year Return
- -79.33 %
REGENXBIO Common Stock Stock Fundamentals & Key Indicators
Check REGENXBIO Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$422.4M
EPS (TTM)
-2.9086
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0.26
EBITDA
-241.2M
Revenue (TTM)
87.8M
Profit Margin
0.00%
Return On Equity TTM
-196.43%
REGENXBIO Common Stock vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of REGENXBIO Common Stock with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $422.4M | -79.33% | NA | 0.00% | NA | |
| BUY | $37.7B | 57.21% | 71.21 | 12.55% | NA | |
| BUY | $116.5B | 140.42% | 27.22 | 35.51% | NA | |
| BUY | $63.7B | 13.39% | 14.85 | 29.65% | 0.58% |
Stock Returns calculator for REGENXBIO Common Stock Stock including INR - Dollar returns
The REGENXBIO Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
REGENXBIO Common Stock investment value today
Current value as on today
₹99,327
Returns
Returns from REGENXBIO Common Stock Stock
Dollar Impact
₹8,312 (+8.31%)
Analyst Recommendation on REGENXBIO Common Stock Stock
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for REGENXBIO Common Stock. Average target price of $23.82
REGENXBIO Common Stock Share Price Target
Get share price movements and forecasts by analysts on REGENXBIO Common Stock.
What analysts predicted
67.25%UPSIDE
Target Price
$23.82
Current Price
$7.8
Analyzed by
18 Analysts
Target
$23.82
REGENXBIO Common Stock target price $23.82, a slight upside of 67.25% compared to current price of $7.8. According to 18 analysts rating.
Indian Investors' Interest in REGENXBIO Common Stock Stock
Search interest for REGENXBIO Common Stock Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:16% versus previous 30 day period
REGENXBIO Common Stock Quarterly Profit & Loss
All numbers in Millions USD
REGENXBIO Common Stock Annual Profit & Loss
All numbers in Millions USD
REGENXBIO Common Stock Quarterly Cash Flow
All numbers in Millions USD
REGENXBIO Common Stock Annual Cash Flow
All numbers in Millions USD
REGENXBIO Common Stock News & Key Events
Today's Timeline - 14 May
Thu, 05:11 PM
-REGENXBIO's 1Q 2026 results show revenue decline and net loss, while preparing for RGX-202 commercial launch.
Thu, 09:33 PM
-REGENXBIO reports significant study results for RGX-202, plans for accelerated approval, but shares drop 36.06%.
Insights on REGENXBIO Common Stock
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, RGNX stock has moved up by 17.1%
NO EFFECTAgainst Peers
In the last 3 years, REGENXBIO Inc. Common Stock has experienced a drawdown of -60.8%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 38.7%
- NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.8% return, outperforming this stock by 27.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -61.94M → -90.05M (in $), with an average decrease of 21.3% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 30.33M → 6.39M (in $), with an average decrease of 78.9% per quarter
About REGENXBIO Common Stock
| Organisation | REGENXBIO Common Stock |
| Headquarters | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
| Industry | Biotechnology |
| CEO | Mr. Curran M. Simpson M.S. |
| E-voting on shares | Click here to vote |
Key Management of REGENXBIO Common Stock
Name | Title |
|---|---|
Mr. Mitchell Chan M.B.A. | Executive VP & CFO |
Dr. Olivier Danos Ph.D. | Executive VP & Chief Scientific Officer |
Dr. Ram Palanki Pharm.D. | Executive VP & Chief Commercial Officer |
Ms. Nina Hunter | SVP of Global Regulatory Strategy and Quality |
Mr. Patrick J. Christmas II, J.D. | Executive VP & Chief Strategy and Legal Officer |
Dr. Stephen Pakola M.D. | Executive VP & Chief Medical Officer |
Mr. Craig Malzahn | Executive VP of Product Development & CTO |
Ms. Shiva G. Fritsch | Chief Communications & People Officer |
Dr. Jahannaz Dastgir D.O. | Clinical Development Lead |
Mr. Curran M. Simpson M.S. | President, CEO & Director |
FAQs
What is REGENXBIO Common Stock share price today?
REGENXBIO Common Stock share price today is $7.8 as on at the close of the market. REGENXBIO Common Stock share today touched a day high of $8.57 and a low of $7.85.
What is the 52 week high and 52 week low for REGENXBIO Common Stock share?
REGENXBIO Common Stock share touched a 52 week high of $16.19 on and a 52 week low of $5.46 on . REGENXBIO Common Stock stock price today i.e. is closed at $7.8,which is 51.82% down from its 52 week high and 42.99% up from its 52 week low.
What is REGENXBIO Common Stock's market capitalisation today?
REGENXBIO Common Stock market capitalisation is $0.00T as on .
How to invest in REGENXBIO Common Stock Stock (RGNX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for REGENXBIO Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in REGENXBIO Common Stock Shares that will get you 0.1923 shares as per REGENXBIO Common Stock share price of $7.8 per share as on June 19, 2026 at 8:46 am IST.
What is the minimum amount required to buy REGENXBIO Common Stock Stock (RGNX) from India?
Indian investors can start investing in REGENXBIO Common Stock (RGNX) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in REGENXBIO Common Stock stock (as per the Rupee-Dollar exchange rate as on ).
Based on REGENXBIO Common Stock share’s latest price of $7.8 as on June 19, 2026 at 8:46 am IST, you will get 1.2821 shares of REGENXBIO Common Stock. Learn more about
fractional shares .
What are the returns that REGENXBIO Common Stock has given to Indian investors in the last 5 years?
REGENXBIO Common Stock stock has given -79.33% share price returns and 27.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?